Idera Pharmaceuticals Inc (NASDAQ:
IDRA) gained 5.9% to $3.78. JP Morgan initiated coverage on Idera Pharmaceuticals with an overweight rating. Share volume was 646,000, compared to an all-day average of 516,000
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
